Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncolytics Biotech Inc
ONCY
Primary Symbol:
T.ONC
Healthcare
Biotechnology
Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and...
adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ONC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(112)
•••
spesestsemper
X
View Profile
View Bullboard History
Post by
spesestsemper
on Nov 19, 2024 2:07pm
aio
AIO-KRK-0320ass_s.pdf
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 12:50pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
On October 2023 ONCY reported on multiple surrogate endpoints (highlighted in red below) of the Goblet-1 Phase 2 pancreatic trial (PDAC) involving pelareorep in combination with the ICI atezolizumab.
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(185)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Nov 19, 2024 12:44pm
RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
YES! That says a ton in regard to whether or not Oncy is currently in negotiations with BP. You decide all.
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 12:37pm
RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Should read: ONCY has reported positive Phase 2 mBC final results on the chosen surrogate endpoint of PFS and mOS, and therefore there are no apparent FDA restrictions on ONCY'
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 12:33pm
RE:RE:RE:RE:RE:How does Accelerated Approval work
ONCY has reported positive final results on the chosen surrogate endpoint of PFS and mOS, and therefore there are no apparent FDA restrictions on ONCY's ability to apply for an Accelerated
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 19, 2024 12:16pm
RE:RE:RE:RE:How does Accelerated Approval work
As previously posted : Accelerated Approval provides for a drug to receive a conditional FDA marketing approval based on surrogate endpoints that have demonstrated a clinical
...more
(233)
•••
itntdf
X
View Profile
View Bullboard History
Comment by
itntdf
on Nov 19, 2024 10:55am
RE:RE:RE:RE:RE:How does Accelerated Approval work
note, i see his comment about accelerated approval, but given it takes pela around 4-6 months to actually demonstrate its benefit, that would seem to suggest it wouldn't be sooner that 2h 2025
...more
(185)
•••
CMHarring218431
X
View Profile
View Bullboard History
Comment by
CMHarring218431
on Nov 19, 2024 10:42am
RE:RE:RE:RE:RE:How does Accelerated Approval work
It hurts me to say this to you but I appreciate and thank you for the summation in the last few posts. A lot of irons in the fire. So many indications, I would think, opens up the chances for a
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 18, 2024 7:03pm
RE:RE:RE:RE:How does Accelerated Approval work
This post appears to be missing : inthno/Da-man - you need to listen to the Q3 CC more carefully, since below is what Thomas Heineman exactly stated - confirming that mBC will seek Accelerated
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 18, 2024 6:33pm
RE:RE:CAR-T update
October 30, 2024 - https://stockhouse.com/companies/bullboard?symbol=t.onc&postid=36318862
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 18, 2024 6:31pm
RE:ONCY/ONC.TO - CAR-T - ICIs - Pelareorep & senescent T-cells
October 30, 2024 - " Using CAR-T cells along with oncolytic viruses may enhance the efficacy of CAR-T cell therapy in destroying solid tumors by increasing the tumor penetrance of T cells
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 18, 2024 6:23pm
RE:RE:RE:RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies
Should read: " These following 5 cancers (7 indications) are those in which treatment with pelareorep as a monotherapy or in combination with other cancer agents are being developed
...more
(5316)
•••
Noteable
X
View Profile
View Bullboard History
Comment by
Noteable
on Nov 18, 2024 6:10pm
RE:RE:RE:RE:Oncolytics Biotech Announces Key Progress & Upcoming Studies
These following 7 cancers involve the use of pelareorep as a monotherapy or in combination with other cancer agents and should be affecting something "critical" for ONCY in the next couple
...more
(479)
•••
Peladawn
X
View Profile
View Bullboard History
Comment by
Peladawn
on Nov 18, 2024 5:13pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:How does Accelerated Approval work
Setortired said....."If you, or anyone thing RFK is good for health, then let me sell you a bridge. That's hilarious, because if he was running as a Dem for president, you and every
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden